AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.050
+0.070 (2.35%)
At close: May 4, 2026, 4:00 PM EDT
3.020
-0.030 (-0.98%)
After-hours: May 4, 2026, 4:23 PM EDT
AC Immune Market Cap
AC Immune has a market cap or net worth of $302.56 million as of May 4, 2026. Its market cap has increased by 100.91% in one year.
Market Cap
302.56M
Enterprise Value
214.68M
1-Year Change
100.91%
Ranking
Category
Stock Price
$3.05
Market Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $302.56M, a decrease of -65.12%. That is a compound annual growth rate of -10.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 1, 2026 | 303.20M | -4.29% |
| Dec 31, 2025 | 316.80M | 17.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 308.87M |
| Anavex Life Sciences | 307.67M |
| NervGen Pharma | 305.92M |
| Zentalis Pharmaceuticals | 290.11M |
| Protara Therapeutics | 287.73M |
| C4 Therapeutics | 284.93M |
| Editas Medicine | 283.83M |
| Cellectis | 283.24M |